VDAC3
Voltage-Dependent Anion Channel 3 (VDAC3) is a protein that in humans is encoded by the VDAC3 gene. It is a member of the Voltage-Dependent Anion Channel (VDAC) family, which plays a significant role in the regulation of mitochondrial function and apoptosis. VDAC3, like its counterparts VDAC1 and VDAC2, is located in the outer mitochondrial membrane and is involved in the transport of adenosine triphosphate (ATP), metabolites, and ions in and out of the mitochondria. This transport is crucial for energy production and the regulation of cellular metabolism.
Function[edit | edit source]
VDAC3 functions as a gatekeeper for the entry and exit of mitochondrial molecules, playing a critical role in cellular energy homeostasis. It is involved in the regulation of apoptosis through its interaction with proteins such as Bcl-2 and Bax, which are key regulators of cell death. Despite its structural similarity to VDAC1 and VDAC2, VDAC3 has unique properties and functions, including a lower conductance in some studies, suggesting a more specialized role in mitochondrial physiology.
Structure[edit | edit source]
The structure of VDAC3, as with other VDAC proteins, is characterized by a beta-barrel that spans the outer mitochondrial membrane. This structure forms a pore that allows the selective passage of small molecules, ions, and ATP. The regulation of this pore is critical for maintaining mitochondrial function and, by extension, cellular health.
Genetic Expression[edit | edit source]
The VDAC3 gene is expressed in various tissues, with expression levels and patterns varying among different organisms and cell types. This differential expression suggests that VDAC3 may have tissue-specific roles in addition to its general functions in mitochondrial regulation and apoptosis.
Clinical Significance[edit | edit source]
Alterations in VDAC3 expression and function have been implicated in several diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. Due to its role in apoptosis and energy metabolism, VDAC3 is considered a potential target for therapeutic interventions in diseases characterized by abnormal cell death and metabolic dysfunctions.
Research Directions[edit | edit source]
Current research on VDAC3 is focused on elucidating its specific roles in mitochondrial function, its regulation of apoptosis, and its involvement in disease mechanisms. Understanding the precise functions of VDAC3 and its interactions with other proteins could lead to new therapeutic strategies for diseases associated with mitochondrial dysfunction.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD